Hong Kong stock market anomaly | Livzon Pharmaceutical (01513.HK) up over 7% LZM012 Phase III clinical trial reaches primary study endpoint

According to the AI Finance and Economics App, Lee's Pharmaceutical (01513.HK) surged more than 7%, with a 7.85% increase as of the time of reporting, reaching 39.15 Hong Kong dollars, with a trading volume of 30.7011 million Hong Kong dollars.